Search results

NICE has developed a medtech innovation briefing (MIB) on the Juxta CURES adjustable compression system for treating venous leg ulcers

Result type

Medtech innovation briefing

Published

25 March 2015

Evidence-based recommendations on baricitinib for treating moderate to severe atopic dermatitis in adults.

Result type

Technology appraisal guidance

Published

3 March 2021

Evidence-based recommendations on abrocitinib (Cibinqo), tralokinumab (Adtralza) or upadacitinib (Rinvoq) for treating moderate to severe atopic dermatitis.

Result type

Technology appraisal guidance

Published

3 August 2022

Evidence-based recommendations on chlormethine gel (Ledaga) for treating early-stage mycosis fungoides-type cutaneous T-cell lymphoma in adults.

Result type

Technology appraisal guidance

Published

18 August 2021

Evidence-based recommendations on adalimumab (Humira), etanercept (Enbrel) and ustekinumab (Stelara) for plaque psoriasis in children and young people.

Result type

Technology appraisal guidance

Published

12 July 2017

This guideline covers complex rehabilitation needs after traumatic injury, including assessment and goal setting, rehabilitation plans and programmes, physical, psychological and cognitive rehabilitation, rehabilitation for specific injuries, coordination of rehabilitation in hospital, at discharge and in the community, and commissioning and organising rehabilitation services.

Result type

NICE guideline

Published

18 January 2022